New gel could ease pain and heal wounds for kids with butterfly skin

NCT ID NCT06594393

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study tests a gel called TCP-25 on people with epidermolysis bullosa (EB), a condition that causes fragile skin and painful blisters. About 32 people aged 4 and older with certain types of EB will have two matching wounds treated—one with the study gel and one with a placebo gel. The goal is to see if the gel helps wounds close faster and reduces pain during dressing changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Akademiska sjukhuset

    RECRUITING

    Uppsala, Sweden

  • Andreas Syngros Hospital of Veneral & Dermatological Diseases

    RECRUITING

    Athens, Greece

  • Cincinnati Children's Hospital Medical Center

    RECRUITING

    Cincinnati, Ohio, 45229, United States

  • Hopital St Louis

    RECRUITING

    Paris, France

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, Spain

  • Hospital Of Skin And Venereal Diseases of Thessaloniki

    RECRUITING

    Thessaloniki, Greece

  • Hospital Univ La Paz

    RECRUITING

    Madrid, Spain

  • IDI Istituto Dermopatico dell'Immacolata IRCCS

    RECRUITING

    Rome, Italy

  • San Joan de Deu, SJD Children's hospital Barcelona

    RECRUITING

    Barcelona, Catalonia, Spain

  • University hospital

    RECRUITING

    Lund, Skåne County, 23735, Sweden

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.